Literature DB >> 11052897

Crystallization and initial X-ray diffraction characterization of complexes of FxFG nucleoporin repeats with nuclear transport factors.

R Bayliss1, H M Kent, A H Corbett, M Stewart.   

Abstract

NTF2 and importin-beta are transport factors that mediate nuclear protein import and which interact with nuclear pore proteins (nucleoporins) during translocation from the cytoplasm to the nucleus through nuclear pore complexes. We employed a native gel electrophoresis method to assess the interaction of nucleoporin constructs that contain FxFG sequence repeats with NTF2 and truncation mutants of importin-beta to determine suitable fragments for crystallization. Based on these data, we obtained crystals of complexes between yeast NTF2 and a construct containing five FxFG nucleoporin repeats from the yeast nucleoporin Nsp1p and between a construct containing residues 1-442 of human importin-beta and the same nucleoporin construct. The yeast NTF2-nucleoporin crystals have trigonal symmetry and diffract past 2.8 A resolution using synchrotron radiation, whereas the importin-beta-nucleoporin complex crystals have P2(1)2(1)2 orthorhombic symmetry and diffract past 3.2 A resolution. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052897     DOI: 10.1006/jsbi.2000.4297

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  11 in total

1.  Nucleocytoplasmic transport: a role for nonspecific competition in karyopherin-nucleoporin interactions.

Authors:  Jaclyn Tetenbaum-Novatt; Loren E Hough; Roxana Mironska; Anna Sophia McKenney; Michael P Rout
Journal:  Mol Cell Proteomics       Date:  2012-02-22       Impact factor: 5.911

Review 2.  Flexible gates: dynamic topologies and functions for FG nucleoporins in nucleocytoplasmic transport.

Authors:  Laura J Terry; Susan R Wente
Journal:  Eukaryot Cell       Date:  2009-10-02

3.  MD simulations and FRET reveal an environment-sensitive conformational plasticity of importin-β.

Authors:  Kangkan Halder; Nicole Dölker; Qui Van; Ingo Gregor; Achim Dickmanns; Imke Baade; Ralph H Kehlenbach; Ralf Ficner; Jörg Enderlein; Helmut Grubmüller; Heinz Neumann
Journal:  Biophys J       Date:  2015-07-21       Impact factor: 4.033

Review 4.  The selective permeability barrier in the nuclear pore complex.

Authors:  Christina Li; Alexander Goryaynov; Weidong Yang
Journal:  Nucleus       Date:  2016-09-27       Impact factor: 4.197

5.  Disorder in the nuclear pore complex: the FG repeat regions of nucleoporins are natively unfolded.

Authors:  Daniel P Denning; Samir S Patel; Vladimir Uversky; Anthony L Fink; Michael Rexach
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  A simple thermodynamic description of phase separation of Nup98 FG domains.

Authors:  Sheung Chun Ng; Dirk Görlich
Journal:  Nat Commun       Date:  2022-10-18       Impact factor: 17.694

7.  Structural basis for the interaction between NTF2 and nucleoporin FxFG repeats.

Authors:  Richard Bayliss; Sara W Leung; Rosanna P Baker; B Booth Quimby; Anita H Corbett; Murray Stewart
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

8.  Two Differential Binding Mechanisms of FG-Nucleoporins and Nuclear Transport Receptors.

Authors:  Piau Siong Tan; Iker Valle Aramburu; Davide Mercadante; Swati Tyagi; Aritra Chowdhury; Daniel Spitz; Sarah L Shammas; Frauke Gräter; Edward A Lemke
Journal:  Cell Rep       Date:  2018-03-27       Impact factor: 9.423

9.  Nuclear mRNA export requires specific FG nucleoporins for translocation through the nuclear pore complex.

Authors:  Laura J Terry; Susan R Wente
Journal:  J Cell Biol       Date:  2007-09-17       Impact factor: 10.539

10.  Transportin acts to regulate mitotic assembly events by target binding rather than Ran sequestration.

Authors:  Cyril Bernis; Beth Swift-Taylor; Matthew Nord; Sarah Carmona; Yuh Min Chook; Douglass J Forbes
Journal:  Mol Biol Cell       Date:  2014-01-29       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.